Prosztatarák: vizsgálatok itt: Németország
97 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 2026. november 18.. Ask the study team whether a trial fits you.
- 2. fázisTaking peopleDarolutamide and bipolar androgen therapy for mCRPC patients (DaroBAT)
- Where
- Aachen, Augsburg, Duisburg, Freiburg im Breisgau, Muenster
- Életkor
- 18 év and over
- People
- 60
- Run by
- Universitaet Muenster
See details and how to join2025-521051-23-00 - No phaseTaking peopleReal-world Experience With Lutetium Vipivotide Tetraxetan in Metastatic Castration Resistant Prostate Cancer
- Where
- Aachen, Augsburg, Berlin, Bielefeld, Bonn, Braunschweig, Chemnitz, Cologne, Cottbus, Dortmund, Dresden, Erfurt, Erlangen, Essen, Frankfurt (Oder), Fulda, Halle, Herford, Homburg, Jena, Konstanz, Leipzig, Ludwigshafen, Magdeburg, Mainz, Marburg, Munich, Nuremberg, Regensburg, Rostock, Stuttgart, Trier, Tübingen, Ulm, Würzburg
- Életkor
- 18 év to 99 év
- People
- 500
- Run by
- Novartis Pharmaceuticals
See details and how to joinNCT06517719 - No phaseNot yet taking people in NémetországOnline Adaptive Stereotactic Body Radiotherapy for Localized Prostate Cancer
- Where
- Heidelberg, Munich
- Életkor
- 18 év and over
- People
- 75 worldwide
- Run by
- University of Zurich
See details and how to joinNCT06834152 - 1/2. fázisTaking peopleA Phase I/II Study of Neoadjuvant, Intra-arterial Administration of [177Lu]Lu-PSMA-617 in Subjects with High-risk, Localised or Locally Advanced Prostate Cancer who are Candidates for Radical Prostatectomy (LUPUS)
- Where
- Essen
- Életkor
- 18 év and over
- People
- 22
- Run by
- Universitaetsklinikum Essen AöR
See details and how to join2022-500838-28-00 - No phaseTaking peopleTotal en Bloc Urethra Preservation at Robot-assisted Prostatectomy IDEAL Stage 2a
- Where
- Düsseldorf, Siegen
- Életkor
- 18 év and over
- People
- 60
- Run by
- Sami-Ramzi Leyh-Bannurah
See details and how to joinNCT07678489 - 2. fázisNot yet taking people in NémetországA Long-term Treatment Extension Study of Niraparib in Participants Who Completed a Prior GlaxoSmithKline/TESARO-sponsored Niraparib Study
- Where
- Velbert
- Életkor
- 18 év and over
- People
- 37 worldwide
- Run by
- GlaxoSmithKline
See details and how to joinNCT04641247 · EU 2023-506618-29-00 - 1/2. fázisTaking peopleA FIH, Phase I/IIa, Trial Assessing Feasibility of Administrations of TIL-based Immunotherapy in Patients With Metastatic CRC and PC
- Where
- Frankfurt am Main
- Életkor
- 18 év and over
- People
- 12
- Run by
- CuraCell TX AB
See details and how to joinNCT07255664 · EU 2025-521227-70-00 - 3. fázisNot yet taking people in NémetországPhase III Randomized International Open Label Clinical Trial of Treatment Intensification With Docetaxel Plus Apalutamide in Patients With Metastatic Hormone-sensitive Prostate Cancer Who Did Not Achieve a Deep PSA Response After Initial Treatment With Apalutamide: REINFORCE Trial.
- Where
- Bonn, Goettingen, Halle, Recklinghausen, Rostock
- Életkor
- 18 év and over
- People
- 320 worldwide
- Run by
- Alianza multidisciplinar para la investigación de los tumores genitourinarios -GUARD
See details and how to joinNCT07333066 · EU 2025-524408-30-01 - No phaseTaking peopleUltrahypofractionated, Adaptive Radiation Therapy of Prostate Cancer
- Where
- Jena
- Életkor
- 18 év to 120 év
- People
- 150
- Run by
- Jena University Hospital
See details and how to joinNCT06355050 - 2. fázisNot yet taking people in NémetországPhase 2 trial of ARPI to AR-degrader (BMS-986365) switch for suboptimal PSA-response in mCSPC (eARly-SWITCH).
- Where
- Duisburg, Düsseldorf, Essen, Frankfurt Am Main, Freiburg im Breisgau, Hamburg, Heidelberg, Herne, Jena, München, Nürnberg, Rostock, Tübingen, Ulm, Wuppertal
- Életkor
- 18 év and over
- People
- 42
- Run by
- UroTrials GmbH
See details and how to join2025-523672-23-00 - 4. fázisTaking peopleLong-Term Safety of Lutetium (177Lu) Vipivotide Tetraxetan in Participants With Prostate Cancer
- Where
- Cologne, Essen, Munich, Rostock
- Életkor
- 18 év to 100 év
- People
- 700 worldwide
- Run by
- Novartis Pharmaceuticals
See details and how to joinNCT05803941 · EU 2023-503208-94-00 - 2. fázisTaking peopleSafety and Diagnostic Performance of uPAR PET Imaging in Localised, Untreated Prostate Cancer
- Where
- Chemnitz, Düsseldorf, Hamburg, Munich
- Életkor
- 18 év and over
- People
- 168 worldwide
- Run by
- Curasight
See details and how to joinNCT06474806 · EU 2023-507111-35-00 - No phaseTaking peopleEFFICACY OF INTRAOPERATIVE ARISTA POLYSACCHARIDE APPLICATION ON THE POSTOPERATIVE BLOOD LOSS IN PATIENTS UNDERGOING RARP FOR THE TREATMENT OF PROSTATE CANCER
- Where
- Gronau, Hamburg, Leipzig
- Életkor
- 45 év to 68 év
- People
- 362
- Run by
- St. Antonius Hospital Gronau
See details and how to joinNCT06822036 - No phaseTaking peopleHow Darolutamide Plus Hormone Therapy Works for Men With Advanced Prostate Cancer in Everyday Medical Practice in Germany
- Where
- Locations
- Életkor
- 18 év and over
- People
- 500
- Run by
- Bayer
See details and how to joinNCT07395804 - 1/2. fázisTaking peopleAnti-tumour Activity of (177Lu) rhPSMA-10.1 Injection
- Where
- Aachen, Augsburg, Essen, Marburg, Munich, Regensburg
- Életkor
- 18 év and over
- People
- 82 worldwide
- Run by
- Blue Earth Therapeutics Ltd
See details and how to joinNCT05413850 · EU 2024-511537-35-00 - 1/2. fázisTaking peoplePhotodynamic Therapy of Primary Localized Prostate Cancer With the SpectraCure P18 System
- Where
- Cologne, Rostock
- Életkor
- 18 év and over
- People
- 43 worldwide
- Run by
- SpectraCure AB
See details and how to joinNCT06807359 - No phaseTaking peopleHypofractionated Radiosurgery for Localised Prostate Cancer (HYPOSTAT-III)
- Where
- Erfurt, Frankfurt am Main, Kiel, Munich
- Életkor
- 18 év and over
- People
- 175
- Run by
- University Hospital Schleswig-Holstein
See details and how to joinNCT06914544 - 3. fázisBefejeződöttADT +/- Darolutamide in de Novo Metastatic Prostate Cancer Patients With Vulnerable Functional Ability (PEACE6-Vulnerable)
- Where
- Essen, Hamburg, Münster
- Életkor
- 18 év and over
- People
- 300 worldwide
- Run by
- UNICANCER
See details and how to joinNCT04916613 · EU 2022-502425-18-00 - 1. fázisTaking peopleLong-Term Follow-Up of AvenCell Sponsored CAR-T Cell Clinical Trials
- Where
- Berlin, Dresden, Marburg, Munich, Ulm
- Életkor
- 18 év and over
- People
- 178
- Run by
- AvenCell Therapeutics, Inc.
See details and how to joinNCT07474051 · EU 2025-521717-67-00 - No phaseTaking peoplePROCARE - PROstate Cancer Real World Evidence Registry
- Where
- Aachen, Augsburg, Bayenthal, Bayreuth, Bergisch Gladbach, Berlin, Bonn, Braunschweig, Dessau, Duisburg, Düsseldorf, Erlangen, Essen, Frankfurt am Main, Freiburg im Breisgau, Giessen, Halle, Hamburg, Heidelberg, Herne, Herzberg am Harz, Hildesheim, Jena, Karlsruhe, Kempten (Allgäu), Leipzig, Lübeck, Magdeburg, Mannheim, Marburg, Neunkirchen, Neustadt am Rübenberge, Nuremberg, Nürtingen, Paderborn, Regensburg, Rostock, Trier, Tübingen, Ulm, Wetzlar, Wilhelmshaven, Wuppertal, Würselen, Würzburg
- Életkor
- 18 év and over
- People
- 5000
- Run by
- UroTrials Company (GmbH)
See details and how to joinNCT06835218 - No phaseTaking peopleProstate Cancer Patients Treated With Alternative Radiation Oncology Strategies
- Where
- Heidelberg
- Életkor
- 18 év and over
- People
- 897
- Run by
- University Hospital Heidelberg
See details and how to joinNCT04083937 - No phaseTaking peopleThe MOMENTUM Study: The Multiple Outcome Evaluation of Radiation Therapy Using the MR-Linac Study
- Where
- Tübingen
- Életkor
- 18 év and over
- People
- 8000 worldwide
- Run by
- UMC Utrecht
See details and how to joinNCT04075305 - 4. fázisTaking peopleEffect on Body Movement and Mental Skills in Patients Who Received Gadolinium-based Contrast Media for Magnetic Resonance Examination Multiple Times Within 5 Years
- Where
- Berlin, Tübingen
- Életkor
- 18 év to 64 év
- People
- 2076 worldwide
- Run by
- Guerbet
See details and how to joinNCT04373564 - No phaseTaking peopleEarly Prostate Cancer Recurrence With PSMA PET Positive Unilateral Pelvic Lesion(s)
- Where
- Hamburg
- Életkor
- 18 év to 75 év
- People
- 397
- Run by
- Martini-Klinik am UKE GmbH
See details and how to joinNCT04271579 - No phaseTaking peopleNavigation, Outcomes and Quality-of-life in Prostate Cancer Patients Undergoing PSMA-targeted Surgery
- Where
- Hamburg
- Életkor
- 18 év to 78 év
- People
- 102
- Run by
- Martini-Klinik am UKE GmbH
See details and how to joinNCT07129551